Havrix 1440 1440 Unit

HAVRIX 1440 is a hepatitis A vaccine designed to prevent infection. This inactivated virus suspension is administered intramuscularly for broad immunity.

HAVRIX 1440 is used to protect against hepatitis A virus infection. This vaccine is typically recommended for individuals at risk, such as travelers to regions with high hepatitis A prevalence. It is also used for those with chronic liver disease or other conditions that increase susceptibility to hepatitis A. The vaccine works by stimulating the body's immune response to develop protection against the virus.

Common effects of HAVRIX 1440 may include soreness, redness, or swelling at the injection site. Some individuals may experience mild fever, headache, or fatigue following vaccination. These effects are usually temporary and resolve within a few days.

HAVRIX 1440 should be administered by a healthcare professional. Individuals with a history of severe allergic reactions to vaccine components should avoid this vaccine. It is important to inform your healthcare provider about any medical conditions or allergies before receiving the vaccine.

HAVRIX 1440 may interact with certain medications or other vaccines. It is advisable to discuss your current medications with a healthcare provider before receiving this vaccine. Additionally, avoid alcohol consumption immediately after vaccination, as it may affect the immune response.